Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective ...

A decade after the first introduction of angiography-derived fractional flow reserve (FFR), we are now entering an era in which simplified image-derived solutions could replace invasive assessment ...

Evident Vascular announced that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS ...

旗下子公司深圳微创踪影医疗装备有限公司 (以下简称“微创踪影”)研发生产的血管内超声（Intravascular Ultrasound，IVUS）诊断设备Decypher（天问 ...

Press Release Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence, today announced the ...

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition ...

March 25, 2025--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial intelligence ...

a privately held medical device company that has developed the TIVUS™ Intravascular Ultrasound System. An investigational technology, the TIVUS system is designed to denervate nerves surrounding ...

Evident Vascular, Inc., developer of an intravascular ultrasound (IVUS) platform powered by artificial intelligence and designed ...

SoniVie has raised $85 million to date. SoniVie has developed a tiny intravascular ultrasound device that can selectively denervate nerves around certain blood vessels to treat medical conditions ...